Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Xiaochen Zhou is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner, VARADARAJ, ARCHANA, who is the busiest examiner for the portfolio with 1 pending action. The prosecution is limited to 1 distinct art unit, indicating a narrow technical focus for the current biotechnology-related intellectual property efforts.
The presence of 1 pending office action means that the current workload at the patent office is focused on a single case. VARADARAJ, ARCHANA is the sole examiner responsible for this 1 pending action, making the relationship with this individual critical for the portfolio's immediate progress. Since the case is in 1 distinct art unit, the applicant only needs to navigate the specific procedural environment of that single unit. This concentrated activity allows for a very targeted approach to resolving the 1 outstanding office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VARADARAJ, ARCHANA | 1 | 80.0% | +33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562323 | Composite gel for removing residual stone fragments after lithotripsy | VARADARAJ, ARCHANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562323 | Composite gel for removing residual stone fragments after lithotripsy | VARADARAJ, ARCHANA | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18562323 | Composite gel for removing residual stone fragments after lithotripsy | VARADARAJ, ARCHANA | 1658 | §103§112 | Final Rejection | — | Pending | Nov 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial